학술논문
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma
Document Type
Article
Author
Ellingson, B.M.; Woodworth, D.C.; Leu, K.; Chakhoyan, A.; Raymond, C.; Harris, R.J.; Cloughesy, T.F.; Aftab, D.T.; Schwab, G.M.; Hessel, C.; Holland, J.; Ping, J.; Weitzman, R.; Reardon, D.A.; Wen, P.Y.; De Groot, J.; Prados, M.D.; Schiff, D.; Chamberlain, M.; Mikkelsen, T.; Desjardins, A.; Drappatz, J.
Source
In: Neuro-Oncology . (Neuro-Oncology, 3 September 2018, 20(10):1411-1418)
Subject
Language
English
ISSN
15235866
15228517
15228517